Completed PHASE1 INTERVENTIONAL 3-arm NCT01679002

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

Sponsor: Bial - Portela C S.A.

Conditions Epilepsy

Updated 6 times since 2017 Last updated: Mar 25, 2025 Started: Oct 31, 2003 Primary completion: Dec 31, 2003 Completion: Dec 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Epilepsy, this trial is completed. The trial is conducted by Bial - Portela C S.A. and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — May 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bial - Portela C S.A.

Data source: Bial - Portela C S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• S. Mamede Do Coronado, Portugal